The global spinal implants & devices market size was valued at USD 11.06 billion in 2015 and is anticipated to grow at a CAGR of 5.8% during the forecast period. The key contributing factors for the market growth include increasing prevalence and subsequent increase in the treatment rates of degenerative spine disorders, rapidly growing elderly population, advancements in medical technology, and increasing demand for minimally invasive procedures.
Aging of the population is associated with degeneration of spine and increasing spinal disorders. Changing lifestyle resulting in upsurge in obesity among the population is also one of the key factors propelling the growth. Growing prevalence of spine injuries is anticipated to further contribute to the growth of the market during the forecast period.
According to, the National Spinal Cord Injury Statistical Center, in 2016, the annual incidence of spinal cord injuries in the U.S. was approximately 54 cases per million population or about 17,000 new cases of such injury per year. As per the WHO insights (2013), spinal cord injuries affect between 250,000 and 500,000 people globally each year. Road accidents, falls, violence and sports activities are some of the major causes of these injuries. Furthermore, development of novel and effective technologies in spine care is anticipated to drive the demand for these implants and devices.
Degenerative disc disorders are among the most commonly diagnosed condition and are the leading causes of back and neck pain. According to the American Chiropractic Association, approximately 31 million people in the U.S. suffer from low back pain at any given time. In addition, an estimated USD 50 billion each year is spent on treatment of back pain in the U.S. Thus, degenerative disorders and associated back pains are expected to boost the demand for these implants and devices in the coming years.
Manufacturers in this market are focusing on the introduction of new technologies for developing minimally invasive approaches, minimizing postoperative pain & complications, and enabling faster recovery. The presence of various market players focusing on development of effective technologies in spine treatments and growing research in the field of spine care are some of the factors that further contribute to the market growth.
In 2015, the spinal fusion devices segment held the largest share in the market. The rising demand for fusion treatments due to increasing incidence of spine injuries and disorders is one of the crucial factor responsible for the large share of this segment. The growing demand for minimally invasive fusion systems and robotic fusion techniques further contributes to the large share of this segment.
Spinal fusion devices are used for treating disc degenerative diseases, spine injuries, and other disorders pertaining to the cervical, thoracic, and lumbar areas of the spine. Aging of the population leading to increase in cases of degenerative spine conditions is another key driver for the growth of this segment. Furthermore, technological advancements and increasing demand for 3D imaging technology are likely to boost the demand for these devices.
However, the spinal biologics segment is forecasted to experience the fastest growth rate with a CAGR of 7.0%. Growing awareness among the healthcare professionals regarding the advantages such as minimal invasiveness and reduction in the duration of hospital stays are likely to be the key factors contributing to the highest growth of this segment.
The spinal fusion & fixation technologies segment held the largest share of the market in the year 2015. This technology is majorly used for the treatment of major spine injuries and severe spine disorders such as spondylolisthesis, spinal stenosis, and scoliosis. The growing prevalence of these disorders is attributable to the large share of the segment. In addition, growing awareness of technological advancement among the healthcare professionals is expected to further drive the growth during the forecast period.
However, the motion preservation technologies segment is anticipated to grow at a faster rate with a CAGR of 6.4%. The growing demand for non-fusion spine surgeries among patients suffering from chronic lower back pain is one of the major factors expected to propel the market in the future. Furthermore, increasing patient population suffering from disc damages and degenerative disc diseases are anticipated to impel the market in the coming few years.
The open surgeries segment held the largest share of the market in the year 2015 accounting for about 62.5%. Open surgeries have an important application in alleviating back pain, which is otherwise incurable by medication or other non-surgical treatment options. Open surgeries have set a benchmark amongst other procedures in the treatment of spine injuries and disorders and thus accounted for the largest revenue share of this market.
However, the minimally invasive surgeries (MIS) segment is anticipated to grow at a faster rate with a lucrative CAGR of 8.5% over the forecast period. The potential advantages of MIS over the conventional open surgeries such as lower blood loss, faster recovery, lesser traumas & incisions, and reduced hospital stays are some of the factors expected to boost the adoption of MIS in spine treatments.
The adverse effects & potential drawbacks associated with open surgeries are also anticipated to contribute to the growing adoption of MIS in healthcare. These minimally invasive surgeries provide access to the target, while potentially minimizing the damage to surrounding tissues and anatomical structures. Thus, owing to the various associated advantages, MIS is gaining momentum in recent years.
The laminotomy segment held the largest share of the market in the year 2015 accounting for 36.4%. Laminotomy is majorly used in the treatment procedures for osteoarthritis, ankylosing spondylitis, sciatica, and spinal stenosis. The increase in the prevalence of various spinal disorders and the growing adoption of technologically advanced treatment procedures also contribute to the large share of the segment.
However, the foraminotomy segment is anticipated to witness the fastest growth rate over the years. The growing number of surgeries for vertebral compression fracture, joint degenerative disorders, and other back surgeries is one of the factors expected to drive the growth of the segment. Furthermore, increasing acceptance of MIS procedures is anticipated to boost the growth of the segment.
North America dominated the market in 2015 with the highest market share. Key factors that can be attributed to its large share include increasing spinal cord injury cases, availability of enhanced healthcare facilities, and the presence of various organizations such as North American Spine Foundation for raising the awareness levels and providing education to the healthcare professionals and public.
The U.S. is the largest market in this region and across the globe. The increase in demand for spine surgeries coupled with surge in prevalence of spine injuries in this region further contributes to the large market share. According to the National Spinal Cord Injury Statistical Center, in 2017, approximately 285,000 people in the U.S. are estimated to suffer from spinal cord injuries.
Asia Pacific market is anticipated to witness the fastest growth over the forecast period with a growth rate of 7.6%. Improvements in infrastructure & healthcare facilities in the region, rising healthcare expenditure, and high prevalence of spinal cord injuries due to falls, violence, and road accidents are some of the factors driving the growth. Furthermore, the growing sedentary life and changing lifestyle patterns leading to an increasing obesity also drive the growth.
Few market players include LDR Holding Corporations, Orthofix International N.V., Alphatec Spine, Globus Medical, Inc., Zimmer Biomet Holdings, NuVasive, Inc., Stryker Corporation, DePuy Synthes, and Medtronic. These key players focus on increasing the R&D initiatives to enhance the spine care treatments.
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2013 to 2024. For the purpose of this study, Grand View Research has segmented the global spinal implants and spinal devices market report on the basis of product, technology, type of surgery, and type of procedure:
Product Outlook, by Revenue (USD Billion, 2013 - 2024)
Spinal Fusion devices
Vertebral compression fracture treatment devices
Spinal bone growth stimulators
Technology Outlook, By Revenue (USD Billion, 2013 - 2024)
Fusion and fixation technology
Vertebral compression fracture treatment
Motion preservation technologies
Type of Surgery Outlook, By Revenue (USD Billion, 2013 - 2024)
Minimally invasive surgery
Procedure Type Outlook, By Revenue (USD Billion, 2013 - 2024)
Regional Outlook, by Revenue (USD Billion, 2013 - 2024)
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.